2024-11-19 10:48:50
CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Health/ 2023-07-22
CHMP Adopted Positive Opinion for ELZONR...

The CHMP recommended approval of ELZONRIS for the first line treatment of adult patients with BPDCN If approved by the European Commission,E...

China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results
Corporate/ 2023-07-23
China Pharma Holdings, Inc. Reports Thir...

HAIKOU,China,Nov. 14,2020-- China Pharma Holdings,Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We&...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release